Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_assertion description "[The most important serological markers reflect the tumor load (beta-2 microglobulin, beta 2-M), proliferative activity (lactic dehydrogenase, LDH), and invasive potential of lymphomas (CA 125).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_assertion evidence source_evidence_literature NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_assertion SIO_000772 10569136 NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_assertion wasDerivedFrom befree-20140225 NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_assertion wasGeneratedBy ECO_0000203 NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP753012.RAGWB2jbz6WYUlS9ntNjgwIuyFikG0Mdp_F7MsxlYOka0130_provenance.